Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Neoplasms, Colorectal Neoplasms, Genital Neoplasms, Female or Toxicity Due to Chemotherapy
and you are
between 18 and 75
years old
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

This study investigates whether it is feasible to teach cancer patients undergoing chemotherapy to self-administer daily moxibustion to reduce chemotherapy side effects. Moxibustion is a therapy used in traditional Chinese medicine that uses heat.

Provided treatments

  • Other: Moxibustion
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02781155. The sponsor of the trial is East and North Hertfordshire NHS Trust and it is looking for 25 volunteers for the current phase.
Official trial title:
Using Daily Self-administered Indirect Moxibustion to Zusanli St-36 to Reduce Chemotherapy Induced Pancytopenia: a Feasibility Study